High Systemic Immune-Inflammation Index Predicts Poor Survival in Patients with Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer Receiving Adjuvant Trastuzumab
2020 ◽
Vol Volume 12
◽
pp. 475-484
◽
2016 ◽
Vol 27
(2)
◽
pp. 160-161
2015 ◽
Vol 22
(8)
◽
pp. 2517-2525
◽
2020 ◽
2011 ◽
Vol 11
(3)
◽
pp. 153-160
◽
2016 ◽
Vol 34
(6)
◽
pp. 521-523
◽